Using whole-exome sequencing, it was demonstrated that TERT, RTEL1, and PARN mutations occur in patients with rheumatoid arthritis-associated ILD at a 3-fold higher odds ratio than they do in a control population. This evidence concerns the gene PARN and interstitial lung disease.